QUAKER CHEMICAL CORPORATION Research and Development Expense
QUAKER CHEMICAL CORPORATION (KWR) reported Research and Development Expense of $60.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-02-23
- QUAKER CHEMICAL CORPORATION research and development expense for fiscal 2025 was $60.70M, a 5.93% increase from fiscal 2024.
- QUAKER CHEMICAL CORPORATION research and development expense for fiscal 2024 was $57.30M, a 13.92% increase from fiscal 2023.
- QUAKER CHEMICAL CORPORATION research and development expense for fiscal 2023 was $50.30M, a 9.35% increase from fiscal 2022.
- QUAKER CHEMICAL CORPORATION research and development expense for fiscal 2022 was $46.00M, a 2.45% increase from fiscal 2021.
| Period end | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $60.70M 10-K · filed 2026-02-23 | |
| 2024-12-31 | $57.30M 10-K · filed 2026-02-23 | |
| 2023-12-31 | $50.30M 10-K · filed 2026-02-23 | |
| 2022-12-31 | $46.00M 10-K · filed 2025-02-24 | |
| 2021-12-31 | $44.90M 10-K · filed 2024-02-29 | |
| 2020-12-31 | $40.00M 8-K · filed 2023-08-03 | |
| 2019-12-31 | $32.10M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $24.50M 10-K · filed 2021-03-01 | |
| 2017-12-31 | $23.90M 10-K · filed 2020-03-20 | |
| 2016-12-31 | $22.50M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $22.10M 10-K · filed 2018-02-28 | $22.09M 10-K · filed 2016-02-25 |
| 2014-12-31 | $22.10M 10-K · filed 2017-02-28 | $22.13M 10-K · filed 2015-02-26 |
| 2013-12-31 | $21.58M 10-K · filed 2016-02-25 | |
| 2012-12-31 | $19.99M 10-K · filed 2015-02-26 | |
| 2011-12-31 | $18.81M 10-K · filed 2014-02-28 | |
| 2010-12-31 | $15.69M 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VALVOLINE INC (VVV) | United States | $3.618B | 49.71 |